Home › Funds › Venrock Adviser, LLC › XFOR

Venrock Adviser, LLC position in XFOR

X4 PHARMACEUTICALS INC · Health Care

Venrock Adviser, LLC reported holding 7,644,072 shares of XFOR (X4 PHARMACEUTICALS INC) in its Q3 2026 13F filing — a position valued at US$22.2M, representing 1.08% of its reported portfolio and ranking #22 among its reported holdings. Venrock Adviser, LLC has disclosed XFOR holdings in 3 of the last 3 reported quarters, going back to Q1 2026.

Latest position (Q3 2026)7.64M sh
Reported value held$22.17M
Portfolio Weight1.08%
First reportedQ1 2026
Last changeAdd
Updated2026-11-17

Last updated: 2026-11-17 · Source: SEC EDGAR Form 13F-HR

How Venrock Adviser, LLC's XFOR position evolved

Venrock Adviser, LLC first disclosed a stake in XFOR in Q1 2026 at 330,525 shares (US$1.4M). The position peaked in Q3 2026 at 7,644,072 shares, worth US$22.2M. Across 3 filings, Venrock Adviser, LLC increased the stake 2 time(s), trimmed it 0 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 7,644,072 shares valued at US$22.2M — an increase of 5,709,819 shares quarter over quarter.. Notable position changes include a 485% increase in Q2 2026 (shares fell 38% over the following quarter), a 295% increase in Q3 2026 (shares fell 2% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q1 2026 330.52K $1.37M New
Q2 2026 1.93M $9.03M Add
Q3 2026 7.64M $22.17M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About XFOR and 13F data

XFOR (X4 PHARMACEUTICALS INC) is a Health Care company. 36 other funds we track also report a position in XFOR — the largest reported positions include Empery Asset Management, LP (US$28.2M), Bain Capital Life Sciences Investors, LLC (US$23.1M), Saturn V Capital Management LP (US$21.4M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding XFOR

All XFOR fund holders →

FAQ

How long has Venrock Adviser, LLC held XFOR?

Venrock Adviser, LLC has disclosed XFOR holdings in 3 of the last 3 reported quarters, going back to Q1 2026.

What is Venrock Adviser, LLC's current position in XFOR?

As of Q3 2026, Venrock Adviser, LLC holds 7.64M shares of XFOR (X4 PHARMACEUTICALS INC), valued at $22.17M, representing 1.08% of its reported portfolio and ranking #22.

Has Venrock Adviser, LLC been buying or selling XFOR?

In the latest 13F filing (Q3 2026), Venrock Adviser, LLC increased its position in XFOR. The position peaked in Q3 2026 at 7.64M shares.

Which other funds hold XFOR?

Other major institutional holders of XFOR include Empery Asset Management, LP, Bain Capital Life Sciences Investors, LLC, Saturn V Capital Management LP, among 36 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.